Answers are grounded in this paper and cite their sources.
Doxorubicin (DOX) conjugated magnetic silica nanoparticles (DOX–Fe3O4–SiO2) are successfully fabricated using a new one-pot method without need for the process of inconvenient multistep synthesis in advance, based on the condensation of DOX and the silica precursor 3-isocyanatopropyltriethoxysilane (ICPTES), followed by the spontaneous formation of a silica coating onto the surface of Fe3O4nanoparticlesvia sol–gel polymerization of triethoxysilane. Mass spectroscopy provides evidence that doxorubicin is conjugated to ICPTES via a urea bond (–NHCONH–) via the reaction of the amino groups of DOX with the isocyanate group (–NCO) of ICPTES in water. The obtained magnetic nanoparticles are well dispersed. Their mean diameter is about 66.9 nm with a narrow size distribution. The conjugated DOX–SiO2–Fe3O4nanoparticles exhibited a higher loading efficiency of 60.5 ± 3.7% and a more sustained release profile than SiO2nanoparticles containing physically-entrapped DOX. It is anticipated that fine-tuning of other drugs or bioactive molecules containing –NH2groups to Fe3O4/SiO2nanoparticles would foster innovative avenues for the development of smart drug delivery and controlled release systems.
No takes yet. Share an insight, caveat, or question.
Li et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: